![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Aventis Pharma Deutschland Gmbh Bad Soden De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Aprotinin concentrated solution, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2000-385 - Rev 01
This TSE Type CEP, issued on February 18, 2005, remains in force until January 24, 2007, ensuring its reliability within the pharmaceutical industry.
Substance Number 579 associated with this CEP further emphasizes